Amprius Technologies Inc’s recently made public that its President of Amprius Lab Bornstein Jonathan unloaded Company’s shares for reported $0.3 million on Apr 02 ’24. In the deal valued at $2.38 per share,125,983 shares were sold. As a result of this transaction, Bornstein Jonathan now holds 558,930 shares worth roughly $1.3 million.
Then, Bornstein Jonathan sold 40,200 shares, generating $111,579 in total proceeds. Upon selling the shares at $2.78, the President of Amprius Lab now owns 0 shares.
Before that, Bornstein Jonathan sold 109,800 shares. Amprius Technologies Inc shares valued at $320,462 were divested by the President of Amprius Lab at a price of $2.92 per share. As a result of the transaction, Bornstein Jonathan now holds 0 shares, worth roughly $0.0.
ROTH MKM initiated its Amprius Technologies Inc [AMPX] rating to a Buy in a research note published on January 11, 2024; the price target was $10. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in mid December with a ‘”a Mkt perform”‘ rating. Alliance Global Partners began covering AMPX with “Buy” recommendation on December 05, 2023. H.C. Wainwright started covering the stock on October 31, 2023. It rated AMPX as “a Buy”.
Price Performance Review of AMPX
On Monday, Amprius Technologies Inc [NYSE:AMPX] saw its stock jump 6.39% to $2.33. Over the last five days, the stock has gained 23.94%. Amprius Technologies Inc shares have fallen nearly -55.95% since the year began. Nevertheless, the stocks have fallen -72.43% over the past one year. While a 52-week high of $10.63 was reached on 01/02/24, a 52-week low of $1.56 was recorded on 04/25/24. SMA at 50 days reached $2.40, while 200 days put it at $3.93. A total of 0.71 million shares were traded, compared to the trading of 0.53 million shares in the previous session.
Levels Of Support And Resistance For AMPX Stock
The 24-hour chart illustrates a support level at 2.24, which if violated will result in even more drops to 2.14. On the upside, there is a resistance level at 2.38. A further resistance level may holdings at 2.42. The Relative Strength Index (RSI) on the 14-day chart is 59.71, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.36, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 0.00%. Stochastics %K at 94.76% indicates the stock is a selling.
The most recent change occurred on June 02, 2023 when Northland Capital began covering the stock and recommended ‘”an Outperform”‘ rating along with a $16 price target.
